Top Markets
Coin of the day
Apollomics, Inc. Apollomics, Inc.

Apollomics, Inc.

APLM
주식 순위 #25246
Apollomics, Inc., a biotechnology enterprise established in 2015 and... Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.
주가
$23.57
마지막 동기화: 2026-08-20
시가총액
$51.76M
변동 (1일)
-0.08%
변동 (1년)
289.59%
국가
US
거래 Apollomics, Inc. (APLM)

카테고리

Apollomics, Inc. (APLM)의 주식 분할 이력
Apollomics, Inc. 주식 (심볼: APLM)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 21, 2026에 발생했습니다.
Aug 21, 2026 이전에 매수한 APLM 주식 1주는 현재 0주의 APLM 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US